Effects of atropine eye drops on eye alignment and vision
Official title: The Effects of Atropine Eyedrops on Ocular Alignment and Binocular Vision
Run by Eye & ENT Hospital of Fudan University · NCT05379855 · Data updated 2026-11-12
This study is testing if low doses of atropine eye drops can help children aged 5 to 14 with eye alignment issues and myopia see better and slow down their vision problems.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 5 Years to 14 Years |
| Sex | All |
| Enrollment | 339 (estimated) |
| Sponsor | Eye & ENT Hospital of Fudan University Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | March 2, 2024 |
| Main results expected | February 1, 2027 |
| Study ends | February 1, 2027 |
| Registry record updated | February 25, 2025 |
| Trial ID | NCT05379855 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 5 to 14 years with specific types of exotropia or myopia and no significant ocular or systemic health issues.
✕Probably not a fit
Patients with amblyopia or those with serious heart or respiratory diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of low concentration atropine eye drops on ocular alignment and binocular vision in children aged 5 to 14 years with conditions such as exotropia and myopia. Participants will be randomly assigned to receive either 0.01% or 0.05% atropine drops or a placebo, with the aim of assessing the efficacy of atropine in slowing myopia progression and improving eye alignment. The study will monitor changes in accommodation and ocular alignment over a specified period, contributing to understanding the long-term effects of atropine treatment.
Why it matters
Potential benefit: If successful, this treatment could significantly slow the progression of myopia and improve ocular alignment in affected children.
How similar studies have gone: Previous studies have shown promising results with low concentration atropine in managing myopia, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The age ranged from 5 to 14 years; * Astigmatism \< 2.5D, spherical power: - 1.00D \~ -6.00D; difference between eyes in spherical power \< 1.5D, difference between eyes in astigmatism \< 1.00D; * Intraocular pressure \< 21mmHg; * Ocular alignment fulfilling the following criteria:Exophoria with an exodeviation at near \> 6PD12; Intermittent exotropia with an exodeviation ≤25 PD both at distance and at near, Titmus \<=400 arc seconds; Intermittent exotropia patients underwent strabismus surgery, 6 months after operation, fulling the criteria of exophoria and intermittent exotropia mentioned before. * Subjects and their parents or legal guardians have signed informed consent and are willing to accept randomized grouping and regular follow-up. Exclusion Criteria: * Amblyopia * Have heart disease or serious respiratory disease * Allergic to atropine, cyclopentantone, propoxybenzocaine and benzalkonium chloride; * Those who have used contact lenses, bifocal lenses, or other measures to control myopia (including atropine); * No binocular vision; * Combined with vertical strabismus≥5PD, abnormal oblique muscle function≥ 2+, cyclodeviation, DVD or A-V pattern, paralytic and restrictive strabismus, comitant esotropia; * Previous history of other ocular surgery; * Severe complications during or after strabismus surgery, such as perforation of the sclera, tear and detachment of extraocular muscle; postoperative eye movement limitation; visual acuity decreased after operation; * Combined with other ocular diseases; * Craniofacial malformations affecting the orbits; * significant neurological disorders; * Birth less than 34 weeks or birth weight less than 1500 g; * Intraocular pressure \> 21mmhg; * Unable to cooperate with the examination.
Where it's running
-
Eye and ENT Hospital, Fudan University
Shanghai, China Recruiting
Study contacts
- Study coordinator: Lianqun Wu, Doctor
- Email: wulianqun19@aliyun.com
- Phone: +8613022110637
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating a device for screening vision problems in young children
This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.
-
Optimizing light exposure to prevent and control myopia in children
This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.
-
Hyperopic reserve screening for kindergartners in Beijing
A population-wide screening tests whether senior kindergarten children in Beijing have enough hyperopic reserve to help prevent future myopia.
-
Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses
This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.
-
Two monthly silicone hydrogel multifocal toric contact lenses in wearers with astigmatism and myopia
This study tests whether two popular soft multifocal toric contact lenses perform differently in adults who need vision correction for astigmatism and myopia.
-
Seeing clearly in low light after Ray-Tracing guided LASIK
A trial tests how well WaveLight Plus LASIK works for people with myopia and astigmatism and whether patients are satisfied after the procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.